Castle Biosciences Inc (CSTL)
24.33
+1.49
(+6.52%)
USD |
NASDAQ |
May 03, 16:00
24.28
-0.05
(-0.21%)
After-Hours: 20:00
Castle Biosciences Accounts Receivable (Quarterly): 42.70M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 42.70M |
December 31, 2023 | 38.30M |
September 30, 2023 | 37.00M |
June 30, 2023 | 31.31M |
March 31, 2023 | 27.73M |
December 31, 2022 | 23.48M |
September 30, 2022 | 22.84M |
June 30, 2022 | 22.61M |
March 31, 2022 | 19.91M |
December 31, 2021 | 17.28M |
September 30, 2021 | 18.53M |
Date | Value |
---|---|
June 30, 2021 | 17.82M |
March 31, 2021 | 14.29M |
December 31, 2020 | 12.76M |
September 30, 2020 | 12.62M |
June 30, 2020 | 12.53M |
March 31, 2020 | 14.60M |
December 31, 2019 | 14.65M |
September 30, 2019 | 12.37M |
June 30, 2019 | 9.730M |
March 31, 2019 | 9.229M |
December 31, 2018 | 12.09M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
9.730M
Minimum
Jun 2019
42.70M
Maximum
Mar 2024
21.15M
Average
18.17M
Median
Accounts Receivable (Quarterly) Benchmarks
Exact Sciences Corp | 203.62M |
Illumina Inc | 734.00M |
Mettler-Toledo International Inc | 663.89M |
Waters Corp | 702.17M |
Natera Inc | 278.29M |